Capital Analysts LLC’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Capital Analysts LLC's LGND Position: Q3 2026 in Review
Capital Analysts LLC opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 3 shares worth $937. The stake represents ﹤0.01% of the portfolio and ranks #1556 among its holdings.
432 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Capital Analysts LLC held 3 shares of Ligand Pharmaceuticals worth $937 as of Q3 2026.
- Ligand Pharmaceuticals was a new Capital Analysts LLC position in Q3 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1556 holding.
- 432 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.